Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.59 | 0.09 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.51 | 0.09 |